Chemical and Organic Nanoparticles in Restorative Endodontics: Synergistic Potential of Zircon-MTA Combined with Sub-10-Micron Hydrogel Systems

نویسندگان
doi
10.48309/jaoc.2026.584201.1395
چکیده

Regenerative endodontic procedures (REPs) represent a paradigm shift in managing immature permanent teeth with necrotic pulps and open apices, aiming to restore the functionality of the pulp-dentin complex rather than relying on apexification or extraction. Central to REP success is the creation of a sterile, vascularized microenvironment that supports stem cell proliferation and differentiation. Mineral trioxide aggregate (MTA) has become the gold-standard coronal barrier material due to its excellent sealing ability, biocompatibility, and bioactivity—releasing calcium and silicate ions that promote hard-tissue formation. However, MTA alone lacks a three-dimensional scaffold for cell homing and sustained biochemical delivery. Recent advances address this through injectable hydrogels—including chitosan, fibrin, and self-assembling peptides—that mimic the native extracellular matrix, enable cell encapsulation, and allow controlled release of growth factors. Concurrently, nanoparticle engineering—encompassing both synthetic (silver, mesoporous calcium silicate, and zinc oxide) and natural (chitosan, hyaluronic acid, and hydroxyapatite) variants—offers unprecedented spatiotemporal precision. These sub-10-micron systems can sequester and deliver bioactive ions (Ca²⁺ and SiO₄⁴⁻), antimicrobial agents, and genetic modifiers directly to the root canal space while modulating oxidative stress and inflammation. Synergistically, MTA provides a bioactive apical seal, hydrogels furnish cell-friendly scaffolds, and nanoparticles fine-tune the biochemical milieu—with MTA-AgNP, MTA-ZnO/chitosan-antibiotic, and GelMA-based formulations emerging as promising composite strategies. The analysis reveals that the tripartite system achieves synergistic indices of 2.9-4.5 for key outcomes including odontogenic differentiation (3-5 fold upregulation of DSPP and DMP-1), antibacterial efficacy (4-5 log reduction in E. faecalis biofilms), and dentinal tubule penetration (200-400 μm depth). Challenges remain, including standardization of nanoparticle dosages, long-term degradation profiles, and translational safety. Yet, preclinical models demonstrate enhanced vascular ingrowth, dentin-like tissue deposition, and improved root wall thickening. This tripartite strategy holds promise for transforming REPs into predictable, short-term therapies, ultimately preserving natural teeth and reducing prosthetic replacements in young patients .